Course Description
Oncologists and their teams (NPs, PAs, Nurses, and Pharmacists) caring for patients with TNBC
Immune checkpoint inhibitors are improving outcomes in triple-negative breast cancer (TNBC), but it remains crucial to take a patient-centered approach to care. Take part in this dynamic program designed to provide an individualized experience based on your current knowledge of recent and emerging evidence regarding the use of immunotherapy in the neoadjuvant and adjuvant settings. Gain expert insights and immediate feedback through customized education that is tailored to deepen your understanding and clinical skills.
What You’ll Learn From This Course
- Take away these lessons with a curated downloadable resource highlighting the latest evidence, guideline-aligned treatment, and emerging considerations for the use and timing of immunotherapy in early-stage TNBC.
Lessons:
